EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
…, G Valesini, R Van Vollenhoven, KL Winthrop… - Annals of the …, 2010 - ard.bmj.com
Treatment of rheumatoid arthritis (RA) may differ among rheumatologists and currently, clear
and consensual international recommendations on RA treatment are not available. In this …
and consensual international recommendations on RA treatment are not available. In this …
[PDF][PDF] 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the …
…, LW Moreland, J O'Dell, KL Winthrop… - Arthritis care & …, 2012 - Wiley Online Library
The American College of Rheumatology (ACR) most recently published recommendations
for the use of diseasemodifying antirheumatic drugs (DMARDs) and biologic agents in the …
for the use of diseasemodifying antirheumatic drugs (DMARDs) and biologic agents in the …
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline
…, J Van Ingen, D Wagner, KL Winthrop - Clinical Infectious …, 2020 - academic.oup.com
Nontuberculous mycobacteria (NTM) represent over 190 species and subspecies, some of
which can produce disease in humans of all ages and can affect both pulmonary and …
which can produce disease in humans of all ages and can affect both pulmonary and …
The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study
…, M Villar, R Walkiewicz, KL Winthrop… - European …, 2013 - Eur Respiratory Soc
A significant knowledge gap exists concerning the geographical distribution of nontuberculous
mycobacteria (NTM) isolation worldwide. To provide a snapshot of NTM species …
mycobacteria (NTM) isolation worldwide. To provide a snapshot of NTM species …
The emerging safety profile of JAK inhibitors in rheumatic disease
KL Winthrop - Nature Reviews Rheumatology, 2017 - nature.com
Tofacitinib is the first Janus kinase (JAK) inhibitor commercially approved for the treatment
of rheumatoid arthritis. This compound and a number of other JAK inhibitors are currently …
of rheumatoid arthritis. This compound and a number of other JAK inhibitors are currently …
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in …
…, AR Smyth, J Van Ingen, RJ Wallace, KL Winthrop… - Thorax, 2016 - thorax.bmj.com
Non-tuberculous mycobacteria (NTM) are ubiquitous environmental organisms that can cause
chronic pulmonary infection, particularly in individuals with pre-existing inflammatory lung …
chronic pulmonary infection, particularly in individuals with pre-existing inflammatory lung …
Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology
…, A Saulson, E McNelly, KL Winthrop - Clinical Infectious …, 2009 - academic.oup.com
Background . Nontuberculous mycobacteria (NTM) are important human pathogens, yet little
is known about disease prevalence in the United States. Reports suggest prevalence has …
is known about disease prevalence in the United States. Reports suggest prevalence has …
Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease
KL Winthrop, E McNelley, B Kendall… - American journal of …, 2010 - atsjournals.org
… Correspondence and requests for reprints should be addressed to Kevin L. Winthrop, MD,
MPH, CEI/OHSU, 3375 SW Terwilliger Blvd., Portland, OR 97239. E-mail: [email protected] …
MPH, CEI/OHSU, 3375 SW Terwilliger Blvd., Portland, OR 97239. E-mail: [email protected] …
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
…, T Takeuchi, P Verschueren, KL Winthrop… - Annals of the …, 2023 - ard.bmj.com
Objectives To provide an update of the EULAR rheumatoid arthritis (RA) management
recommendations addressing the most recent developments in the field. Methods An international …
recommendations addressing the most recent developments in the field. Methods An international …
Infection risk and safety of corticosteroid use
…, SA Novosad, KL Winthrop - Rheumatic Disease …, 2016 - rheumatic.theclinics.com
Because of their potent anti-inflammatory properties, corticosteroids have been used for
decades to treat many diseases, including rheumatic diseases. They are frequently used in …
decades to treat many diseases, including rheumatic diseases. They are frequently used in …